Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Study of Amlodipine 10mg in Hypertension
NCT00443456Phase 3Completed
- Sponsor
- Pfizer
- Start
- May 2007
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of amlodipine in hypertension (HTN), sponsored by Pfizer. Primary endpoints: Change in Systolic Blood Pressure From Baseline of the Preceding Study at Week 52, Change in Systolic Blood Pressure From Baseline of This Long-term Study at Week 52 and 4 more. Started May 2007; status: completed.
02
Drugs
amlodipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00443456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00443456.